logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9248116 B1

PDFFull Text
Date of Patent:
Feb. 02, 2016

Filed:

Mar. 11, 2013

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

Applicant:

Newron Pharmaceuticals S.p.a., Bresso, IT;

Inventors:

Piero Melloni, Bresso, IT;

Alessandra Restivo, Milan, IT;

Emanuela Izzo, Milan, IT;

Simona Francisconi, Milan, IT;

Elena Colombo, Inverigo, IT;

Cibele Sabido-David, Milan, IT;

Assignee:

NEWRON PHARMACEUTICALS S.P.A., Bresso, IT;

Attorneys:

Silvia Salvadori, P.C.

Silvia Salvadori

Primary Examiner:

Sreeni Padmanabhan

Assistant Examiner:

Sahar Javanmard

Int. Cl.
CPC ...
A61K 31/165 (2006.01); C07C 237/08 (2006.01); C07C 233/05 (2006.01); C07C 233/65 (2006.01); A61K 31/381 (2006.01); C07C 317/28 (2006.01); C07C 323/25 (2006.01); C07C 327/42 (2006.01); C07D 295/182 (2006.01); A61K 31/40 (2006.01); A61K 31/4515 (2006.01); A61K 31/519 (2006.01); A61K 31/5513 (2006.01); C07C 237/06 (2006.01); C07D 207/16 (2006.01); C07D 333/20 (2006.01); C07C 237/20 (2006.01); C07C 321/26 (2006.01); C07C 327/44 (2006.01); A61K 31/137 (2006.01);
U.S. Cl.
CPC ...
A61K 31/381 (2013.01); A61K 31/137 (2013.01); A61K 31/165 (2013.01); A61K 31/40 (2013.01); A61K 31/4515 (2013.01); A61K 31/519 (2013.01); A61K 31/5513 (2013.01); C07C 237/06 (2013.01); C07C 237/08 (2013.01); C07C 237/20 (2013.01); C07C 317/28 (2013.01); C07C 321/26 (2013.01); C07C 323/25 (2013.01); C07C 327/42 (2013.01); C07C 327/44 (2013.01); C07D 207/16 (2013.01); C07D 295/182 (2013.01); C07D 333/20 (2013.01);
Abstract

Substituted 2-[2-(phenyl)ethylamino]alkaneamide derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing them are useful as sodium and/or calcium channel modulators for preventing, alleviating and curing pathologies wherein the above mechanisms play a pathological role. The compounds may be particularly useful for the prevention, alleviation, and curing of, for example, neurological, cognitive, psychiatric, inflammatory, urogenital and gastrointestinal diseases.

Find Patent Forward Citations

Loading…